Skip to content

Fresh Capital for Nanomedicine Development against Chronic Inflammatory Autoimmune Diseases

Hannover / Potsdam, January 15, 2020. 

Rodos Biotarget GmbH implemented financing measures over € 2.3 million. All of the company’s current investors have participated in the accompanying capital increase. The majority of capital was raised from ILB – the business promotion bank in the federal state of Brandenburg – and their ERDF-Subsidy “ProFIT” (€ 1.8 million).

News press link

Medical Park Hannover

Feodor-Lynen-Str. 31
30625 Hannover / Germany

Potsdam Science Park

Am Mühlenberg 11
14476 Potsdam / Germany